Pharma > Product or Service Promotion
FINGERPAINT, New Jersey / ENDO PHARMACEUTICALS / 2022
Overview
Credits
Write a short summary of what happens in the film
Because people living with Dupuytren’s contracture are subject to such misinformation, we wanted to give them what they want most—clear and consistent answers. And we wanted to do it through the widest platform possible: broadcast television. Our film brought real people living with Dupuytren’s contracture from across the country together for a conversation with a Hand Specialist.
Our real people were able to ask questions and share their stories, creating an open and honest dialogue that we filmed and pushed out across the major news networks and entertainment channels.
Describe any restrictions or regulations regarding Healthcare/RX/Pharma communications in your country/region including:
This unbranded healthcare campaign for Dupuytren’s contracture was reviewed and approved by Endo Pharmaceuticals after a thorough internal promotional review process, which included review by members of Legal, Regulatory, and Medical, to determine that all communications and content are consistent with FDA regulations governing this type of disease awareness campaign.
Describe the target audience and why your work is relevant to them.
There’s a lot of conflicting information about Dupuytren’s contracture and its treatments. So much so that many people with Dupuytren’s contracture don’t even know nonsurgical treatments exist and are left confused and frustrated as their condition worsens—a call we couldn’t help but answer.
More Entries from Regulated: Direct to Consumer in Pharma
24 items
More Entries from FINGERPAINT
24 items